nach oben

International Urology and Nephrology

Erschienen in:

18.07.2019 | Urology - Original Paper

Evaluation of the urinary podocalyxin and nephrin excretion levels to determine a safe time interval between two sessions of SWL for renal stones: a non randomized exploratory study

verfasst von: Hüseyin Kocatürk, Nursen Atasoy, Fevzi Bedir, İbrahim Karabulut, Engin Şebin, Kemal Sarica

Erschienen in: International Urology and Nephrology | Ausgabe 10/2019

Einloggen, um Zugang zu erhalten

Abstract

Objectives

We aimed to evaluate the role of nephrin and podocalyxin in determining the intervals between shock wave lithotripsy (SWL) sessions and how soon the kidney damage was recovered.

Methods

This work was a prospective study that included 30 patients with unilateral kidney stones. The patients’ midflow urine samples were collected before SWL and 1 h, 1 day and 1 week after the procedure. Nephrin and podocalyxin levels in the urine samples were measured by the enzyme-linked immunosorbent assay method.

Results

Among the 30 patients who underwent SWL, 19 were males and 11 were females. The mean age of the SWL group was 34.7 ± 13.2. Both biomarkers did not correlate with age, creatinine values, body mass index, stone side, stone size, energy, frequency and shock numbers. Nephrin and podocalyxin levels were significantly higher at the pre-SWL point (p < 0.05). After the procedure, a significant decrease was observed in both biomarker levels (p < 0.05). At the end of first day, these levels started to increase progressively up to the end of the first week (p > 0.05).

Conclusions

Nephrin and podocalyxin may help to determine early period kidney damage associated with SWL. Post-SWL podocalyxin and nephrin values may be used to determine the interval between SWL sessions.

Romero V, Akpinar H, Assimos DG (2010) Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol 12(2–3):e86–e96PubMedPubMedCentral

Cohen TD, Durrani AF, Brown SA, Ferraro R, Preminger GM (1998) Lipid peroxidation induced by shockwave lithotripsy. J Endourol 12(3):229–232PubMedCrossRef

Willis LR, Evan AP, Connors BA, Blomgren P, Fineberg NS, Lingeman JE (1999) Relationship between kidney size, renal injury, and renal impairment induced by shock wave lithotripsy. J Am Soc Nephrol 10(8):1753–1762PubMed

Lingeman JE, McAteer JA, Kempson SA, Evan AP (1988) Bioeffects of extracorporeal shockwave lithotripsy: strategy for research and treatment. Urol Clin N Am 15:507

Recker F, Hofmann W, Bex A, Tscholl R (1992) Quantitative determination of urinary marker proteins: a model to detect intrarenal bioeffects after extracorporeal lithotripsy. J Urol 148(3):1000–1006PubMedCrossRef

Mundel P, Shankland SJ (2002) Podocyte biology and response to injury. J Am Soc Nephrol. 13:3005–3015PubMedCrossRef

Camici M (2007) Urinary detection of podocyte injury. Biomed Pharmacother 61(5):245–249PubMedCrossRef

Kerjaschki D, Sharkey DJ, Farquhar MG (1984) Identification and characterization of podocalyxin–the major sialoprotein of the renal glomerular epithelial cell. J Cell Biol 98(4):1591–1596PubMedCrossRef

Kerosuo L, Juvonen E, Alitalo R, Gylling M, Kerjaschki D, Miettinen A (2004) Podocalyxin in human haematopoietic cells. Br J Haematol 124:809–818PubMedCrossRef

10.

Kershaw DB, Beck SG, Wharram BL, Wiggins JE, Goyal M, Thomas PE, Wiggins RC (1997) Molecular cloning and characterization of human podocalyxin-like protein. Orthologous relationship to rabbit PCLP1 and rat podocalyxin. J Biol Chem 272:15708–15714PubMedCrossRef

11.

Casey G, Neville PJ, Liu X, Plummer SJ, Cicek MS, Krumroy LM, Curran AP, McGreevy MR, Catalona WJ, Klein EA, Witte JS (2006) Podocalyxin variants and risk of prostate cancer and tumor aggressiveness. Hum Mol Genet 15:735–741PubMedCrossRef

12.

Larrucea S, Butta N, Arias-Salgado EG, Alonso-Martin S, Ayuso MS, Parrilla R (2008) Expression of podocalyxin enhances the adherence, migration, and intercellular communication of cells. Exp Cell Res 314:2004–2015PubMedCrossRef

13.

Kestilä M, Lenkkeri U, Männikkö M, Lamerdin J, McCready P, Putaala H, Ruotsalainen V, Morita T, Nissinen M et al (1998) Positionally cloned gene for a novel glomerular protein—nephrin—is mutated in congenital nephrotic syndrome. Mol Cell 1:575–582PubMedCrossRef

14.

Aström E, Rinta-Valkama J, Gylling M, Ahola H, Miettinen A, Timonen T, Holthöfer H (2006) Nephrin in human lymphoid tissues. Cell Mol Life Sci 63:498–504PubMedCrossRef

15.

Karalezli G, Gögüş O, Bedük Y, Köküuslu C, Sarica K, Kutsal O (1993) Histopathologic effects of extracorporeal shock wave lithotripsy on rabbit kidney. Urol Res 21(1):67–70PubMedCrossRef

16.

Sarica K, Ozer G, Soygür T, Yaman O, Ozer E, Ustün H, Yaman LS, Göğüş O (1997) Preservation of shock-wave-induced renal histologic changes by dermatan sulfate. Urology 49(1):145–150PubMedCrossRef

17.

Krysiewicz S (1992) Complications of renal extracorporeal shock wave lithotripsy reviewed. Urol Radiol 13(3):139–145PubMed

18.

Biri H, Oztürk HS, Büyükkoçak S, Kaçmaz M, Cimen MY, Unal D, Birey M, Bozkirli I, Durak I (1998) Antioxidant defense potential of rabbit renal tissues after ESWL: protective effects of antioxidant vitamins. Nephron 79(2):181–185PubMedCrossRef

19.

Kaude JV, Williams CM, Miliner MR, Scott KN, Finlayson B (1985) Renal morphology and function immediately after extracorporeal shock-wave lithotripsy. AJR Am J Roentgenol 145(2):305–313PubMedCrossRef

20.

Bomanji J, Boddy S, Britton KE, Nimmon CC, Whitfield HN (1987) Radionuclide evaluation pre and post-extracorporeal shock wave lithotripsy for renal calculi. J Nucl Med 28(8):1284–1289PubMed

21.

Sarıca K, Kosar A, Yaman O, Bedük Y, Durak I, Göğüş O, Kavukçu M (1996) Evaluation of ischemia after SWL: detection of free oxygen radical scavenger enzymes in renal parenchyma subjected to high-energy shock waves. Urol Int 57(4):221–223PubMedCrossRef

22.

Neal DE Jr, Kaack MB, Harmon EP, Puyau F, Morvant A, Richardson E, Thomas R (1991) Renin production after experimental extracorporeal shock wave lithotripsy: a primate model. J Urol 146(2 (Pt 2)):548–550PubMedCrossRef

23.

Strohmaier WL, Carl AM, Wilbert DM, Bichler KH (1996) Effects of extracorporeal shock wave lithotripsy on plasma concentrations of endothelin and renin in humans. J Urol 155(1):48–51PubMedCrossRef

24.

Yurdakul T, Kulaksizoglu H, Pişkin MM, Avunduk MC, Ertemli E, Gokçe G, Barişkaner H, Byükbaş S, Kocabas V (2010) Combination antioxidant effect of α-tocoferol and erdosteine in ischemia-reperfusion injury in rat model. Int Urol Nephrol 42(3):647–655PubMedCrossRef

25.

Thamilselvan S, Byer KJ, Hackett RL, Khan SR (2000) Free radical scavengers, catalase and superoxide dismutase provide protection from oxalate-associated injury to LLC-PK1 and MDCK cells. J Urol 164(1):224–229PubMedCrossRef

26.

Zhu B, Li XF, Zhu XL, Lin Y, Zhong S, Zhu CF, Tang XL, Hu YQ, Cheng XX, Wang YJ (2014) ELISA analysis of urinary nephrin and podocalyxin standardized by aquaporin-2 in adult patients with nephrotic syndrome. J Nephrol 27(4):411–417PubMedCrossRef

27.

Matovinović MS (2009) Podocyte ınjury in glomerular diseases. eJIFCC 20(1):21–27PubMedPubMedCentral

28.

Whiteside C, Porutis K, Cameron R, Thomson J (1989) Glomerular epithelial detachment not reduced charge density correlates with proteinuria in adriamycin and puromycin nephrosis. Lab Investig 61:650–660PubMed

29.

Hara M, Yamamoto T, Yanagihara T, Takada T, Itoh M, Adachi Y, Yoshizumi A, Kawasaki K, Kihara I (1995) Urinary excretion of podocalyxin indicates glomerular epithelial cell injuries in glomerulonephritis. Nephron 69:397–403PubMedCrossRef

30.

Andersson M, Nilsson U, Hjalmarsson C, Haraldsson B, Nystrom JS (2007) Mild renal ischemia-reperfusion reduces charge and size selectivity of the glomerular barrier. Am J Physiol Renal Physiol 292:F1802–F1809PubMedCrossRef

31.

Koop K, Eikmans M, Baelde HJ, Kawachi H, De Heer E, Paul LC, Bruijn JA (2003) Expression of podocyte-associated molecules in acquired human kidney diseases. J Am Soc Nephrol 14(8):2063–2071PubMedCrossRef

32.

Jim B, Ghanta M, Qipo A, Fan Y, Chuang PY, Cohen HW, Abadi M, Thomas DB, He JC (2012) Dysregulated nephrin in diabetic nephropathy of type 2 diabetes: a cross sectional study. PLoS One 7(5):e36041PubMedPubMedCentralCrossRef

33.

Hara A, Wada T, Furuichi K, Sakai N, Kawachi H, Shimizu F, Shibuya M, Matsushima K, Yokoyama H, Egashira K, Kaneko S (2006) Blockade of VEGF accelerates proteinuria, via decrease in nephrin expression in rat crescentic glomerulonephritis. Kidney Int 69(11):1986–1995PubMedCrossRef

34.

Shao Y, Connors BA, Evan AP, Willis LR, Lıfshıtz DA, Lıngeman JE (2003) Morphological changes induced in the pig kidney by extracorporeal shockwave lithotripsy: nephron injury. Anat Rec A Discov Mol Cell Evol Biol 275(1):979–989PubMedCrossRef

35.

Wang Y, Zhao S, Loyd S, Groome LJ (2012) Increased urinary excretion of nephrin, podocalyxin, and βig-h3 in women with preeclampsia. Am J Physiol Renal Physiol 302(9):F1084–F1089PubMedCrossRef

36.

Obermüller N, Geiger H, Weipert C, Urbschat A (2014) Current developments in early diagnosis of acute kidney injury. Int Urol Nephrol 46(1):1–7PubMedCrossRef

37.

Sirota JC, Klawitter J, Edelstein CL (2011) Biomarkers of acute kidney injury. J Toxicol 2011:328120PubMedPubMedCentralCrossRef

38.

Aydin HR, Irkilata L, Aydin M, Daggulli M, Taskin MH, Demirel HC, Adanur S, Moral C, Atilla MK, Sancaktutar AA (2016) The application of kidney injury molecule-1 to determine the duration between shock wave lithotripsy sessions. J Endourol 30(1):109–113PubMedCrossRef

39.

Turk C, Petrik A, Seitz C, Skolarikos A, Thomas K, Neisius A et al (2018) Guidelines on urolithiasis (limited text update March 2017), pp 1–81. http://uroweb.org. 13 Mar 2017

40.

Kira VM, Fagundes DJ, Bandeira CO, Fagundes AT, Ortiz V (2007) The repeated extracorporeal shockwaves and the renal parenchyma injury on normal and diabetic rats. Acta Cir Bras 22(4):285–290PubMedCrossRef

Titel: Evaluation of the urinary podocalyxin and nephrin excretion levels to determine a safe time interval between two sessions of SWL for renal stones: a non randomized exploratory study
verfasst von: Hüseyin Kocatürk
Nursen Atasoy
Fevzi Bedir
İbrahim Karabulut
Engin Şebin
Kemal Sarica
Publikationsdatum: 18.07.2019
Verlag: Springer Netherlands
Erschienen in: International Urology and Nephrology / Ausgabe 10/2019
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI: https://doi.org/10.1007/s11255-019-02229-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Evaluation of the urinary podocalyxin and nephrin excretion levels to determine a safe time interval between two sessions of SWL for renal stones: a non randomized exploratory study

Abstract

Objectives

Methods

Results

Conclusions

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Objectives

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2019

MicroRNA-1246 regulates the radio-sensitizing effect of curcumin in bladder cancer cells via activating P53

Intravesical application of platelet-rich plasma in patients with persistent haemorrhagic cystitis after hematopoietic stem cell transplantation: a single-centre preliminary experience

Intravenous infusion of ulinastatin attenuates acute kidney injury after cold ischemia/reperfusion

The impact of microbiome in urological diseases: a systematic review

Reversed connection of cuffed, tunneled, dual-lumen catheters with increased blood flow rate maintains the adequacy of delivered dialysis despite the higher access recirculation

Organ-sparing procedures in GU cancer: part 2-organ-sparing procedures in testicular and penile tumors

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin